Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alternative wound care treatment for percutaneous gastrostomy site infection (silver dressings vs topical fusidate)
2011-001251-37Phase 4Active
- Sponsor
- Amsterdam University Medical Center
- Start
- Apr 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of fusidic acid in Percutaneous endoscopic gastrostomy site infection, Device Infection and cutaneous infection (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: Healing of PEG site infection at 2 weeks. Started Apr 2011; status: active.
02
Drugs
fusidic acid
03
Conditions
Percutaneous endoscopic gastrostomy site infectionDevice Infectioncutaneous infection
Beyond the preview
Go deeper on 2011-001251-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001251-37.